Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/TAS-108> ?p ?o }
Showing triples 1 to 72 of
72
with 100 triples per page.
- TAS-108 abstract "TAS-108, also known as SR16234, is a drug discovered by Masato Tanabe and under development by SRI International and Taiho Pharmaceutical. It is a steroid hormone that has shown signs of treating and preventing breast cancer, even in patients where tamoxifen has failed.".
- TAS-108 atcPrefix "L02".
- TAS-108 atcSuffix "BA".
- TAS-108 casNumber "229634-98-4".
- TAS-108 iupacName "(7α,17β)-17-(2-{4-[(Diethylamino)methyl]-2-methoxyphenoxy}ethyl)-7-methylestra-1,3,5(10)-trien-3-ol 2-hydroxy-1,2,3-propanetricarboxylate (1:1)".
- TAS-108 pubchem "9874874".
- TAS-108 thumbnail TAS-108.png?width=300.
- TAS-108 wikiPageID "38628029".
- TAS-108 wikiPageLength "5569".
- TAS-108 wikiPageOutDegree "15".
- TAS-108 wikiPageRevisionID "682005148".
- TAS-108 wikiPageWikiLink Angiogenesis.
- TAS-108 wikiPageWikiLink Apoptosis.
- TAS-108 wikiPageWikiLink Breast_cancer.
- TAS-108 wikiPageWikiLink Category:Experimental_cancer_drugs.
- TAS-108 wikiPageWikiLink Category:SRI_International.
- TAS-108 wikiPageWikiLink Category:Steroid_hormones.
- TAS-108 wikiPageWikiLink Category:Taiho_Pharmaceutical.
- TAS-108 wikiPageWikiLink Masato_Tanabe.
- TAS-108 wikiPageWikiLink National_Institute_of_Health.
- TAS-108 wikiPageWikiLink National_Institutes_of_Health.
- TAS-108 wikiPageWikiLink SRI_International.
- TAS-108 wikiPageWikiLink Steroid_hormone.
- TAS-108 wikiPageWikiLink Taiho_Pharmaceutical.
- TAS-108 wikiPageWikiLink Tamoxifen.
- TAS-108 wikiPageWikiLinkText "SR16234".
- TAS-108 wikiPageWikiLinkText "TAS-108".
- TAS-108 atcPrefix "L02".
- TAS-108 atcSuffix "BA".
- TAS-108 c "39".
- TAS-108 casNumber "229634".
- TAS-108 chemspiderid "8050563".
- TAS-108 drugName "TAS-108".
- TAS-108 h "55".
- TAS-108 hasPhotoCollection TAS-108.
- TAS-108 iupacName "-17".
- TAS-108 molecularWeight "697.85".
- TAS-108 n "1".
- TAS-108 o "10".
- TAS-108 pubchem "9874874".
- TAS-108 smiles "O=CCCCO.OC".
- TAS-108 stdinchi "InChI=1S/C33H47NO3.C6H8O7/c1-6-3421-23-8-13-3037-17-15-25-9-12-29-32-2218-24-20-2610-11-272814-16-334;7-31-62-410/h8,10-11,13,19-20,22,25,28-29,32,35H,6-7,9,12,14-18,21H2,1-5H3;13H,1-2H2,/t22-,25-,28-,29+,32-,33-;/m1./s1".
- TAS-108 stdinchikey "VOHOCSJONOJOSD-SCIDSJFVSA-N".
- TAS-108 wikiPageUsesTemplate Template:Drugbox.
- TAS-108 wikiPageUsesTemplate Template:MeshName.
- TAS-108 wikiPageUsesTemplate Template:Reflist.
- TAS-108 subject Category:Experimental_cancer_drugs.
- TAS-108 subject Category:SRI_International.
- TAS-108 subject Category:Steroid_hormones.
- TAS-108 subject Category:Taiho_Pharmaceutical.
- TAS-108 hypernym Drug.
- TAS-108 type ChemicalSubstance.
- TAS-108 type Company.
- TAS-108 type Drug.
- TAS-108 type Company.
- TAS-108 type Drug.
- TAS-108 type Hormone.
- TAS-108 type Steroid.
- TAS-108 type ChemicalObject.
- TAS-108 type Thing.
- TAS-108 type Q8386.
- TAS-108 comment "TAS-108, also known as SR16234, is a drug discovered by Masato Tanabe and under development by SRI International and Taiho Pharmaceutical. It is a steroid hormone that has shown signs of treating and preventing breast cancer, even in patients where tamoxifen has failed.".
- TAS-108 label "TAS-108".
- TAS-108 sameAs m.0r8k6l5.
- TAS-108 sameAs TAS-108.
- TAS-108 sameAs TAS-108.
- TAS-108 sameAs Q7669355.
- TAS-108 sameAs Q7669355.
- TAS-108 wasDerivedFrom TAS-108?oldid=682005148.
- TAS-108 depiction TAS-108.png.
- TAS-108 isPrimaryTopicOf TAS-108.
- TAS-108 name "TAS-108".